Company: AEMD
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001683168-25-006049
Chunk: 50

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 8
Chunk 50
---
 92121. Our telephone number is (619) 941-0360. Our
website address is www.aethlonmedical.com.

Our common stock is listed on the Nasdaq Capital Market under the symbol
“AEMD.”

WHERE YOU CAN FIND MORE INFORMATION

We are subject to the informational requirements of
the Exchange Act, and must file reports, proxy statements and other information with the SEC. The SEC maintains a website (http://www.sec.gov)
that contains reports, proxy and information statements and other information regarding registrants, like us, which file electronically
with the SEC.

 19 

RESULTS OF OPERATIONS

THREE MONTHS ENDED JUNE 30, 2025 COMPARED TO THE THREE MONTHS ENDED JUNE
30, 2024

Operating Expenses

Consolidated operating expenses for the three months
ended June 30, 2025 were $1,792,390 compared to $2,620,858 for the three months ended June 30, 2024. This decrease of $828,468, or 31.6%,
in the 2025 period was due to a decrease of $673,802 in payroll and related $138,050 in professional fees and $16,616 in general and administrative
expenses.

The $673,802 decrease in payroll and related expenses
for the three months ended June 30, 2025, was primarily due to the absence of a $320,604 severance accrual recorded in the prior year
related to the separation of an executive. The remaining decrease reflects a $286,311 reduction in compensation costs associated with
lower headcount, as well as a $66,886 decline in stock-based compensation related to the same reduction in workforce.

The $138,050 decrease in professional fees for the
three months ended June 30, 2025, was primarily driven by a $104,387 reduction in legal fees following the transition to a new legal firm,
a $33,720 decline in scientific consulting costs due to the conclusion of a project, a $23,219 decrease in auditor fees, primarily reflecting
lower audit-related costs compared to the prior period and an $18,118 reduction in contract labor following the completion of a regulatory
project and transition to lower-cost quality management system consultants. These decreases were partially offset by a $41,835 increase
in investor relations expenses related to the special meeting of stockholders.

General and administrative expenses decreased by $16,616
for the